人工智慧（AI）診斷市場：按組件、診斷類型和地區分類

Artificial Intelligence Diagnostics Market, By Component, By Diagnostics Type, By Region

出版日期: 2026年03月26日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，人工智慧（AI）診斷市場規模將達到26.803億美元，到2033年將達到104.162億美元。預計從2026年到2033年，該市場將以21.4%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	26.803億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	21.40%	2033年市場規模預測：	104.162億美元

人工智慧（AI）在醫療領域擁有巨大的潛力，有望快速、詳細地分析大量數據。它有可能對體外診斷（IVD）等領域產生變革性影響。因此，醫療領域對人工智慧技術的需求正在不斷成長。

市場動態

隨著人工智慧（AI）的開發和應用，醫療診斷實踐正在迅速變革。電腦處理能力的不斷提升，使得基於人工智慧的系統能夠在各個學科領域提供精準高效的診斷和治療方案。憑藉其強大的運算能力、先進的學習演算法、雲端儲存技術的進步以及電子健康記錄資料集的可用性，人工智慧在診斷和醫療領域能夠發揮重要作用。這使得放射科醫師和病理學家能夠更早地準確診斷病情，並提供適當有效的治療。

一篇發表於2017年12月PubMed的報導探討了人工智慧在放射學領域的應用，指出下一個突破並非源自於創新的放射學設備，而是人工智慧的整合。預計這一整合將分階段進行。人工智慧驅動的設備能夠擷取來自超音波、磁振造影（MRI）、電腦斷層掃描（CT）和正子斷層掃描（PET）等影像技術的資料。作為第一步，人工智慧已經能夠對各種影像資料和結構進行自動分割，從而產生顯著的分析價值，並幫助放射科醫生節省時間。未來十年，人工智慧驅動的放射學解決方案將用於在放射科醫生分析之前執行量化、分割和模式識別等常規任務，從而改善患者照護。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究基於公司亮點、產品系列、主要特徵、財務表現和策略等參數，分析了全球人工智慧診斷市場的主要參與者。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
這份全球人工智慧（AI）診斷市場報告的目標受群眾外包括行業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球人工智慧診斷市場分析中使用的各種策略矩陣來簡化決策過程。

Report Coverage	Report Details
Base Year:	2025	Market Size in 2026:	USD 2,680.3 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	21.40%	2033 Value Projection:	USD 10,416.2 Mn

Artificial intelligence (AI) has powerful potential within healthcare, promising the ability to analyze vast amounts of data quickly and in detail. In a field such as in vitro diagnostics (IVD), which could have transformative implications. Thus, there is an increasing demand for artificial intelligence technology in healthcare sector.

Market Dynamics

The practice of medical diagnostics is rapidly changing with the development and adoption of Artificial Intelligence (AI). Constant improvements in computer processing have enabled AI-based systems to provide accurate and efficient diagnosis & treatment management plans across various specializations. AI can play a big role in diagnosis and healthcare, with advancements in computing power, learning algorithms, cloud storage, and availability of datasets from electronic health records. It can enable radiologists and pathologists to accurately diagnosis conditions at an early stage to provide adequate & effective treatment.

In a PubMed article on applications of AI in radiology, in December 2017, it was studied that the next breakthrough would not be through an innovative radiology device but through the integration of AI. This integration is likely to take place in stages. AI-based devices are collecting data from imaging technologies, such as ultrasound, MRI, CT, and PET. In its first stage, AI is already performing automatic segmentation of various imaging data and structures to yield significant analytical value and help save the radiologist's time. Over the next decade, AI-based radiology solutions are likely to be used to perform routine tasks such as quantification, segmentation, and pattern recognition prior to the radiologist's analysis, thereby improving patient care delivery.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global artificial intelligence (AI) diagnosis market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Vuno Inc., CHC Healthcare Group, Aidoc, Imbio, Alivecor Inc., Digital Diagnostics, Retina AI, Canon Medical Systems USA, Healthy Io, Milliman Inc., GE Healthcare, Arterys, Alivecor Inc., Riverain, Lucid Health, Qure.AI, and Cardiologs, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global artificial intelligence (AI) diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence (AI) diagnosis market.

Market Segmentation

Global Artificial Intelligence Diagnostics Market, By Component (Revenue, USD Mn, 2021 - 2033)
Software
Hardware
Services
Global Artificial Intelligence Diagnostics Market, By Diagnosis Type (Revenue, USD Mn, 2021 - 2033)
Cardiology
Oncology
Pathology
Radiology
Neurology
Others
Global Artificial Intelligence Diagnostics Market, By Geography (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
Vuno Inc.
CHC Healthcare Group
Aidoc
Imbio
Alivecor Inc.
Digital Diagnostics
Retina AI
Canon Medical Systems USA
Healthy IO
Milliman Inc.
GE Healthcare
Arterys
Alivecor Inc.
Riverain
Lucid Health
Qure.AI
Cardiologs

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Component
- Market Snapshot, By Service Type
- Market Snapshot, By Geography
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Rising incidence of infectious diseases
Concerns about the use of thermometers
High demand for Artificial Intelligence (AI) diagnostics devices
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Artificial Intelligence (AI) Diagnostics Market, By Component, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Hardware
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

5. Global Artificial Intelligence (AI) Diagnostics Market, By Diagnostics Type, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Pathology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Radiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

6. Global Artificial Intelligence (AI) Diagnostics Market, By Geography, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - South Africa
  - North Africa
  - Central Africa

7. Competitive Landscape

Vuno Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CHC Healthcare Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Aidoc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Imbio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alivecor Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Digital Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Retina AI
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Canon Medical Systems USA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Healthy IO
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Milliman Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Arterys
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alivecor Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Riverain
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lucid Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Qure.AI
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cardiologs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views